Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.

Mediterranean diets that include some lean red meat can still boost cardiovascular health
The study's authors focused on blood pressure reductions and arterial stiffness, sharing their findings in Current Developments in Nutrition.
Plant-based diets may help patients with diabetes, heart disease live longer
Researchers focused on data from nearly 78,000 adults with cardiometabolic disorders, sharing their findings at ACC.25 in Chicago.
Oral semaglutide reduces heart risks while helping patients move past ‘fear of the needle’
Researchers still think patients should receive an injectable version of semaglutide when possible, but new data out of ACC.25 confirm that an oral formulation of the drug is associated with significant benefits.
‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes
Patients who present with type 2 diabetes and PAD often face substantial mobility issues. According to new data presented at ACC.25, however, treatment with semaglutide could represent a major step forward for this high-risk population.
A glass of orange juice a day may help keep the cardiologist away
Drinking orange juice is associated with several interactions in the body that may help combat the risks of cardiac remodeling.

FDA announces new recall of blood pressure medication due to potential cancer risk

Patients impacted by this recall are advised to speak with a physician about how to proceed.

E-cigarettes linked to AFib, other heart rhythm issues in ‘highly concerning’ new study

“The findings of this study are important because they provide fresh evidence that the use of e-cigarettes could interfere with normal heart rhythms—something we did not know before,” according to one specialist.

cocaine heart failure HFrEF LVEF hospitalizations beta-blockers hypertension cardiology

Marijuana, meth, cocaine and opiates all linked to heart rhythm issues

Reviewing data from more than 23.5 million U.S. patients, the study's authors found that methamphetamine use was linked to a whopping 86% increase in a patient's AFib risk. The other substances included in the analysis were not far behind.

Deepak Bhatt, MD, MPH, executive director of the interventional cardiovascular programs at Brigham and Women’s Hospital, and professor of medicine at Harvard Medical School, explained the new generation of cholesterol lowering agents and their roles in various types of patients.

VIDEO: Deepak Bhatt discusses the role of new cholesterol-lowering agents

Deepak Bhatt, MD, a professor of medicine at Harvard Medical School, details the new generation of cholesterol-lowering agents and their roles in patient care.

New evidence that heart damage risk is much higher after COVID-19 infection than after vaccination

The new meta-analysis, published in Frontiers in Cardiovascular Medicine, included data from 58 million patients. “We hope our findings will help mitigate vaccine hesitancy and increase vaccine uptake," one researcher said.

Metformin, the popular type 2 diabetes medication, may be an effective AFib treatment

A team of specialists from Cleveland Clinic reviewed nearly 3,000 medications, writing that a common type 2 diabetes medication offered the most potential as an effective treatment for AFib.

The FDFA has cleared tirzepatide (Mounjaro) from Eli Lilly for the treatment of diabetes.

FDA grants fast track designation to tirzepatide, Eli Lilly’s new type 2 diabetes drug, for treating obesity

Back in May, tirzepatide was approved by the FDA for improving glycemic control among adults with type 2 diabetes.

FDA recall. The medications involved are atenolol, which treats hypertension, and clopidogrel, which reduces the risk of an acute myocardial infarction (AMI) or stroke among patients with a history of AMI, severe chest pain or circulation problems.

FDA announces recall of 2 cardiovascular medications due to labeling mix-up

Patients face a risk of adverse events if they mistakenly take the wrong medication, according to a new warning from the FDA.

Heart Health

Mediterranean diets that include some lean red meat can still boost cardiovascular health

Plant-based diets may help patients with diabetes, heart disease live longer

Oral semaglutide reduces heart risks while helping patients move past ‘fear of the needle’

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes

A glass of orange juice a day may help keep the cardiologist away